Abstract Details

Title Fremanezumab Reduces Headache Pain within the First Week of Beginning Treatment in the Phase 2 Episodic Migraine Study

Topic Headache

Presentation(s) P4 - (-)

Poster/Presentation
Number 114

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Marcelo E. Bigal, MD, PhD (Purdue) PRESENTER	No disclosure on file
Ernesto Aycardi, MD (Kyowa Kirin)	Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
	No disclosure on file
Robert Noble	No disclosure on file
Pippa S. Loupe, PhD	No disclosure on file

��ɫ��